AVTX
NASDAQ · Biotechnology
Avalo Therapeutics Inc
$7.76
+0.06 (+0.78%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+324.1% upside
Low Target
$27.78
Average Target
$32.91
High Target
$47.11
Current Price
$7.76
Current
$7.76
$7.76
Target
$32.91
$32.91
$27.78
$32.91 avg
$47.11
Scenario Analysis
Bear Case
$27.78
258.0%
Low target
Base Case
$32.91
+324.1%
Avg target
Bull Case
$47.11
+507.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$24.27
-68.0% from high
52-Week Low
$6.53
+18.8% from low
Target vs 52W High
$32.91
+35.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |